Retroperitoneal nodal metastases from colorectal cancer: Curable metastases with radical retroperitoneal lymphadenectomy in selected patients

• Published in: European journal of surgical oncology Vol. 41; no. 6; pp. 731 - 737
• Main Authors: Gagnière, J., Dupré, A., Chabaud, S., Peyrat, P., Meeus, P., Rivoire, M.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.06.2015
• Subjects: Adult; Aged; Chemotherapy, Adjuvant; Colorectal neoplasms; Colorectal Neoplasms - drug therapy; Colorectal Neoplasms - pathology; Colorectal Neoplasms - surgery; Disease-Free Survival; Female; Hematology, Oncology and Palliative Medicine; Humans; Length of Stay; Long-term survival; Lymph Node Excision; Lymph nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm metastasis; Neoplasm Recurrence, Local - pathology; Neoplasm Staging; Retroperitoneal Space; Retrospective Studies; Surgery; Survival Rate; RNM; Long-term survival; CRC; RLR; Colorectal neoplasms; Neoplasm metastasis; RRL; Lymph nodes; Lymph node excision; colorectal cancer; retroperitoneal nodal metastases; radical retroperitoneal lymphadenectomy; retroperitoneal local recurrence

Retroperitoneal nodal metastases (RNM) represent 1–2% of metastases from colorectal cancer (CRC). Non-surgical treatments achieve 5-year overall survival (OS) of 0–12%. Radical retroperitoneal lymphadenectomy (RRL) in this setting remains controversial, but most published series do not distinguish l...